| Financial Year |
March 31 2023 |
| Monetary Funds |
3,425,932,299.13 |
| Held-for-trading Financial Assets |
471,088,573.37 |
| Notes Receivable |
491,469.02 |
| Accounts Receivable |
1,794,554,473.66 |
| Advances to Suppliers |
108,442,363.55 |
| Other Receivables |
118,760,388.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
434,250.00 |
| Inventories |
1,771,810,776.71 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
134,129.21 |
| Other Current Assets |
551,655,752.14 |
| Total Current Assets |
8,257,220,465.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
719,679.48 |
| Long-term Equity Investment |
312,067,627.27 |
| Investment Properties |
468,517,415.34 |
| Fixed Assetes |
909,325,463.44 |
| Under-construction Projects |
1,700,722,125.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,994,066,075.95 |
| R&D expenses |
-- |
| Goodwill |
18,000,315.13 |
| Long-Term Deferred and Prepaid Expenses |
176,289,005.89 |
| Deferred Income Tax Assets |
25,280,944.43 |
| Other Non-Current Assets |
11,617,124.95 |
| Sub-Total of Non-Current Assets |
7,473,746,782.93 |
| Total Assets |
15,730,967,248.90 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
102,860,000.00 |
| Accounts Payable |
4,248,874,726.38 |
| Accounts Received In Advance |
1,875,622.36 |
| Employee Compensation Payable |
265,742,560.42 |
| Taxes Payable |
56,480,677.95 |
| Interest Payable |
-- |
| Dividend Payable |
24,999,312.08 |
| Other payables |
511,615,335.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,952,166.91 |
| Other Current Liabilities |
117,727,947.53 |
| Sub-Total of Current Liabilities |
6,051,588,132.82 |
| Long-term Loans |
789,879,544.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,593,607.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
120,707,970.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,373,920,702.50 |
| Total Liabilities |
7,425,508,835.32 |
| Paid-In Capital(Or Share Stock) |
895,876,566.00 |
| Capital Surplus |
836,527,834.06 |
| Surplus Reserve |
362,755,855.07 |
| LESS:Treasury Stock |
107,216,582.75 |
| Undistributed Profits |
5,473,824,594.66 |
| Minority Stockholder's Interest |
843,690,146.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,461,768,267.04 |
| Owner's Equity（Stockholder's Equity） |
8,305,458,413.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,730,967,248.90 |
